RFK Jr. Eyes Wireless, RF Radiation; Cancer by the Month; AI for Cancer Symptoms

As a first step toward possible health warnings about cell phones, Wi-Fi, and other technologies, HHS Secretary Robert F. Kennedy Jr. has asked for public feedback on effects of electromagnetic fields, radiofrequency radiation, and wireless radiation exposure. (Washington Examiner)

The editors of Clinical Science published an “Expression of Concern” about the “scientific validity” of references cited in an article about the role of hypoxia-inducible factors in breast cancer stem cell phenotype, authored by 2019 Nobel Prize winner Gregg L. Semenza, MD, PhD, who has more than a dozen other retractions.

A young woman in Washington state dismissed her abdominal bloating as a common reaction to stress, but then a “weird” referral for a CT scan led to a diagnosis of stage IV ovarian cancer and “life-saving” enrollment in a clinical trial. (CBS News)

Arizona sued L’Oréal and its U.S. subsidiary, alleging that the company hid evidence that its hair-relaxer products could cause cancer in women. (Reuters via AOL)

Bristol Myers Squibb and Ono Pharmaceutical sued Amgen, alleging the latter’s candidate biosimilar to blockbuster cancer drug nivolumab (Opdivo) violates the plaintiffs’ patents. (Fierce Pharma)

January leads all months with the most cancer diagnoses, whereas December brings up the rear. (JAMA Network Open)

White House Chief of Staff Susie Wiles said she has no evidence of cancer following treatment for early-stage breast cancer. (AP)

Curium announced FDA approval of lutetium Lu 177 dotatate (Bexlutry), the first radioligand equivalent, for a certain type of gastroenteropancreatic neuroendocrine tumor.

The agency also approved Telix’s floretyrosine F 18 (Pixclara), the first FET-PET imaging agent for glioma.

A mosunetuzumab (Celestimo) regimen led to a significant reduction in the risk of progression in previously treated follicular lymphoma as compared with a rituximab (Rituxan) regimen in a phase III trial, Roche said.

A 43-year-old British man with stage III colon cancer talks about how he uses artificial intelligence (AI) to manage symptoms, emotions, and medications. (Business Insider)

A systematic review of trials involving nearly 8,500 cancer patients showed a significant association between structured exercise programs and increased overall and disease-free survival. (British Journal of Sports Medicine)

Meanwhile, a study of 500 patients with cancer showed that mind-body interventions, including tai chi, can help reduce some of the most troublesome symptoms affecting daily living, including sleep disturbance and pain. (University of Calgary)

Researchers said a rare germline mutation, more common in the Appalachia region of the U.S., can confer as much as a 25-fold increase in lung cancer risk. (Dana-Farber Cancer Institute)

CVS Health announced that Aetna will expand its prior authorization bundling program across all types of cancer to streamline the process for providers and patients.

In preclinical models, an aggressive childhood brain cancer grew more slowly when exposed to a currently available anti-seizure medication. (Stanford Medicine)